SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SANOFI INDIA

BSE: 500674 20 Aug 2025
Healthcare
₹ 5177.4
Sanofi India Ltd specializes in Pharmaceuticals within the Healthcare sector.

SANOFI INDIA - Share Price & Details

Market Cap
₹11,847
High /Low
7,600 / 4,146
Stock P/E
26.8
Book Value
₹374.0
Dividend Yield
2.26
ROCE
49.2
ROE
₹47.1
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹22.8
Debt
19.3
CMP / FCF
NA
Debt to equity
₹0.02
NP Ann
413
High price all time
7,600
Piotroski score
₹6.0
Graham Number
1,230
No. Eq. Shares
2.3
Net CF
₹-111
Net profit
413
Price to book value
13.8
Interest Coverage
₹314.0
Low price all time
399.0
Industry PE
33.8
Reserves
₹838
Free Cash Flow
₹426

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
SANOFI INDIA LTD4150.0695.04063.030.1811,84726.8
ACUTAAS CHEMICALS LIMITED2231.75440.112072.375.411143160.5
GRANULES INDIA LTD.8233.6694.858102.082.861111223.3

Peer Comparison Chart


About SANOFI INDIA

Sanofi India Ltd, with Security Code 500674, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Sanofi Consumer Healthcare India Limited launches Allegra-D in India: Non-Drowsy Allergy Relief with...

(08 Aug 2025)
Sanofi Consumer Healthcare India Limited, one of India's leading consumer healthcare organisations, has announced the launch of Allegra-D,...
Read more →

Sanofi India Reports Growth in Operating Profit Amid Sales Decline

(08 Aug 2025)
Sanofi India Limited ( ($IN:SANOFI) ) has issued an update. Sanofi India Limited reported a 2% decline in net sales year-to-date but achieved a 6% ...
Read more →

Four Pharma stocks that should be on your radar ahead of Tuesday's trade

(05 Aug 2025)
Aurobindo Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA), margins and net profit was also significantly...
Read more →

Sanofi Consumer Healthcare India Limited reports 28% revenue growth in Q2 Profit up 21% at ₹607 million

(05 Aug 2025)
Chennai, 05 August 2025: Sanofi Consumer Healthcare India Limited (BSE:544250 I NSE: SANOFICONR) announced strong financial results for the second quarter...
Read more →

Sanofi India Second Quarter 2025 Earnings: EPS: ₹30.18 (vs ₹29.61 in 2Q 2024)

(05 Aug 2025)
NSEI:SANOFI 1 Year Share Price vs Fair Value Explore Sanofi India's Fair Values from the Community and select yours...
Read more →

Sanofi India Limited (SANOFI) Gets Regulatory Approval - Invest confidently with professional market insights

(04 Aug 2025)
Sanofi India Limited (SANOFI) Gets Regulatory Approval ✌️【Investor Updates】✌️ Access exclusive analysis on market-moving events,...
Read more →

Company Updates